Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by subaru1on Sep 08, 2023 11:02am
87 Views
Post# 35626112

RE:Once LABS is associated with the name of their global pharma

RE:Once LABS is associated with the name of their global pharmaSubaru1i, the way i see that to reach a new 52 week high, first i don't think that we will see that this year unless we got a really really good 3 qrt and then by the end of october we could have a new high. Otherwise we need a very good 4 qrt, Labs might receive the Monograph sometime before mid 2024 and the scheduling 1 to 3 might happen sometimes in the second half of 2024, Labs for me is a very long play like 3 o 5 years until it really moves and please don't come with a stock consolidation thrue that time. I think that Mr Pidduck is doing a good job presently but the reality is that every move takes week, months and year to be realised in the medical marijuana domain. Also there is still to many sellers at $0,075 / $0,08 how many will be available before we hit $0,11. The only things that could propulse this stock to new high is a big news with a big pharma and a revenue associated to that news.

Have a good day everyone.
<< Previous
Bullboard Posts
Next >>